Fujirebio Europe Launches The RoboBlot Instrument, A Fully Automated Solution For INNO-LIA Score Assays
Fujirebio Europe announced the commercial launch of the RoboBlot instrument, a closed system for the automated processing of the widely used INNO-LIA Score assays. The instrument is manufactured by Bee Robotics Ltd. and distributed by Fujirebio Europe. The system’s pre-programmed test protocols provide start-to-finish automation of strip-based INNO-LIA Score assays, from sample addition, over strip processing, image capture, to result interpretation and where applicable laboratory information system (LIS) communication.
Recommended AI News: TacoCat Partners With Phantasma To Integrate Smart NFT Technology
“High throughput testing and more automation are an increasingly pressing need for laboratories. The typical drawbacks of manual testing, such as long hands-on time, inconsistent assay handling and issues with traceability, will become part of the past,” said Christiaan De Wilde, CEO at Fujirebio Europe. “The RoboBlot instrument will radically improve the laboratory workflow for our customers, from tedious manual or semi-automated work into fully automated testing.”
RoboBlot extends the range of automated solutions already offered by Fujirebio Europe for the INNO-LIA Score assay portfolio. It offers high-throughput testing, full automation with pipetting up to 50 samples and integrated camera for scanning and interpretation with Fujirebio LiRAS software, providing complete traceability with minimal hands-on time. It offers a customized fit with individual laboratory needs. Other automated solution for this portfolio is the TENDIGO®.
More information about RoboBlot can be found in our website and the instrument will be on display during the Medlab meeting from the 24th to the 27th of January 2022 in Dubai at the Fujirebio booth (booth Z5.C15)
Please contact your local sales representative for the availability of these products in your country.
Recommended AI News: Himo World NFT Metaverse Gears Up For IDO
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.